New breast cancer drug candidate tested in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study tests whether a new drug called KSHN001034 is safe and how the body processes it compared to an existing breast cancer drug, Faslodex. About 40 healthy postmenopausal women will receive either the new drug or Faslodex at different doses. The goal is to chec…
Phase: PHASE1 • Sponsor: Kashiv BioSciences, LLC • Aim: Knowledge-focused
Last updated May 17, 2026 02:05 UTC